Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae [Corrigendum]

Read full text Summarise with VIRAT
Authors: Diandian Chen, He Lan, Wenshuo Yang, Dequan Tian, Yuan Liu, Leyang Ju, Qiao Song, Rong Min, Yan Wang, Ying Li, P.F. Wang, Jingrong Cao
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chen D, Lan H, Yang W, et al. Infect Drug Resist. 2026;19:1—13. https://doi.org/10.2147/IDR.S583973 There is an unintentional textual error in Figure 1 on page 4 of the published paper, the text “(n=4: CRAB, n=3; CRKP, n=1)” should read “(n=20: CRAB, n=15; CRKP, n=5)”. The authors apologize for the error and advise that it was purely a labelling oversight and does not alter the statistical analysis, results, or the scientific conclusions of the paper. The correct Figure 1 is shown below. Figure 1 Experimental Workflow.

Fields of Study & Subjects

Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Antibiotic Use and Resistance

Publication details

Journal / source
Dove Medical Press (Taylor and Francis Group)
Publication date
23 March 2026
Language
EN